DR. SARAH UTZ PETRY M.D.
Prescription History 1982136321
Dermatology in Duluth, MN

NPI Status: Active since April 03, 2017

Contact Information

400 E 3RD ST
DULUTH, MN
ZIP 55805
Phone: (218) 786-8364

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SARAH UTZ PETRY M.D., an active Dermatology specialist practicing in Duluth, MN. Our medical registry currently tracks 18 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 812 documented patient claims. Among these therapy options, the most frequently utilized medication is Ketoconazole, which accounts for 132 claims alone.


Betamethasone Diprop Augmented

Generic Formulation: Betamethasone/Propylene GlycSpecialty: Dermatology
Provider Metrics Summary
Total Claims 35
30-Day Fills 35.1
Days Supply 727
MN State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills39.2
Peer Average Days Supply984
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,240.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$64.01

State Avg Cost Per Claim

$65.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Betamethasone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid.

Calcipotriene

Generic Formulation: CalcipotrieneSpecialty: Dermatology
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 565
MN State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.2
Peer Average Days Supply608
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,617.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$295.65

State Avg Cost Per Claim

$224.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat psoriasis. Calcipotriene is a form of vitamin D. It works by slowing down the growth of skin cells.

Ciclopirox

Generic Formulation: CiclopiroxSpecialty: Dermatology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 268
MN State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.1
Peer Average Days Supply660
Conservative Utilization

This provider writes prescriptions for this formulation 42.9% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $458.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$38.25

State Avg Cost Per Claim

$32.71

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane and pyridinone derivative that is used for the treatment of fungal infections of the skin and nails, and for treatment of VAGINAL YEAST INFECTIONS.

Therapeutic Applications

This medication is used to treat fungal infections of the fingernails and toenails. It is used as part of a treatment program that may include the removal of unattached, infected nails by a health care professional. Ciclopirox works by stopping the growth of fungus.

Clindamycin Phosphate

Generic Formulation: Clindamycin PhosphateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 335
MN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills25.0
Peer Average Days Supply691
Conservative Utilization

This provider writes prescriptions for this formulation 40.9% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $484.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$37.29

State Avg Cost Per Claim

$68.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain type of vaginal infection (bacterial vaginosis) in women who are not pregnant. Clindamycin is an antibiotic which works by stopping the growth of bacteria.

Clobetasol Propionate

Generic Formulation: Clobetasol PropionateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 96
30-Day Fills 100.3
Days Supply 2,560
MN State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills35.9
Peer Average Days Supply917
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 200.0% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,988.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$83.21

State Avg Cost Per Claim

$85.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid.

Desonide

Generic Formulation: DesonideSpecialty: Dermatology
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 336
MN State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills26.7
Peer Average Days Supply610
Conservative Utilization

This provider writes prescriptions for this formulation 44.0% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,760.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$197.14

State Avg Cost Per Claim

$79.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Desonide reduces the swelling, itching and redness that can occur in these types of conditions. Desonide is a mild corticosteroid.

Doxycycline Monohydrate

Generic Formulation: Doxycycline MonohydrateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 111
30-Day Fills 137.0
Days Supply 3,849
MN State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills28.6
Peer Average Days Supply535
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 382.6% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,284.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$38.60

State Avg Cost Per Claim

$25.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.

Therapeutic Applications

This medication is used to treat a certain type of skin condition called rosacea. It helps to reduce the number of pimples and bumps on the face, but it may not decrease redness. It works by reducing skin inflammation caused by rosacea. Although doxycycline belongs to the class of antibiotics known as tetracyclines, this product does not work as an antibiotic because it does not stop the growth of bacteria. Do not use this product to treat any infection, including viral infections (such as the common cold, flu). Use this medication only as prescribed by your doctor.

Fluocinonide

Generic Formulation: FluocinonideSpecialty: Dermatology
Provider Metrics Summary
Total Claims 39
30-Day Fills 41.8
Days Supply 1,175
MN State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills33.4
Peer Average Days Supply878
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 25.8% more claims than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,630.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$67.45

State Avg Cost Per Claim

$70.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topical glucocorticoid used in the treatment of ECZEMA.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, psoriasis, allergies, rash). Fluocinonide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid.

Fluorouracil

Generic Formulation: FluorouracilSpecialty: Dermatology
Provider Metrics Summary
Total Claims 96
30-Day Fills 100.3
Days Supply 2,342
MN State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills36.9
Peer Average Days Supply951
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 174.3% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,157.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$105.81

State Avg Cost Per Claim

$121.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.

Therapeutic Applications

Fluorouracil is used to treat various types of cancer. It is a chemotherapy drug that is used to slow or stop cancer cell growth.

Hydrocortisone

Generic Formulation: HydrocortisoneSpecialty: Dermatology
Provider Metrics Summary
Total Claims 48
30-Day Fills 54.0
Days Supply 1,041
MN State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills33.5
Peer Average Days Supply788
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 84.6% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $414.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.64

State Avg Cost Per Claim

$23.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

Therapeutic Applications

Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal.

Ketoconazole

Generic Formulation: KetoconazoleSpecialty: Dermatology
Provider Metrics Summary
Total Claims 132
30-Day Fills 140.0
Days Supply 3,772
MN State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills41.4
Peer Average Days Supply1,095
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 247.4% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,273.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.38

State Avg Cost Per Claim

$30.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.

Therapeutic Applications

This medication is used to control dandruff. Use of this medication may help to relieve the flaking, scaling and itching associated with dandruff. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Ketoconazole 2% shampoo is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs.

Levocetirizine Dihydrochloride

Generic Formulation: Levocetirizine DihydrochlorideSpecialty: Dermatology
Provider Metrics Summary
Total Claims 29
30-Day Fills 50.0
Days Supply 1,500
MN State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills37.1
Peer Average Days Supply1,076
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.1% more claims than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $910.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.38

State Avg Cost Per Claim

$21.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Levocetirizine does not prevent hives or prevent/treat a serious allergic reaction (such as anaphylaxis). If your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use levocetirizine in place of your epinephrine.

Metronidazole

Generic Formulation: MetronidazoleSpecialty: Dermatology
Provider Metrics Summary
Total Claims 21
30-Day Fills 23.0
Days Supply 528
MN State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills16.0
Peer Average Days Supply121
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 31.3% more claims than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,858.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$88.49

State Avg Cost Per Claim

$35.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.

Therapeutic Applications

This medication is used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. It may help to decrease redness, swelling and the number of pimples caused by rosacea. This medication is an antibiotic. For the treatment of rosacea, metronidazole is believed to work by decreasing swelling (inflammation). Some brands of this medication also contain sunscreens (see also Notes section).

Minocycline Hcl

Generic Formulation: Minocycline HclSpecialty: Dermatology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
MN State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills25.9
Peer Average Days Supply715
Conservative Utilization

This provider writes prescriptions for this formulation 42.1% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $131.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.91

State Avg Cost Per Claim

$38.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.

Therapeutic Applications

This medication is used to treat acne or rosacea. Minocycline belongs to a class of drugs known as tetracycline antibiotics. However, it is not used to treat skin infections. It helps decrease pimples and red bumps that happen with acne or rosacea.

Mupirocin

Generic Formulation: MupirocinSpecialty: Dermatology
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 279
MN State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.9
Peer Average Days Supply470
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $257.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.26

State Avg Cost Per Claim

$11.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Therapeutic Applications

Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.

Tacrolimus

Generic Formulation: TacrolimusSpecialty: Dermatology
Provider Metrics Summary
Total Claims 23
30-Day Fills 27.7
Days Supply 640
MN State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills62.8
Peer Average Days Supply1,824
Conservative Utilization

This provider writes prescriptions for this formulation 39.5% less frequently than the standard regional baseline metric for practitioners inside MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,944.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$214.97

State Avg Cost Per Claim

$221.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.

Therapeutic Applications

Tacrolimus is used with other medications to prevent rejection of a kidney transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.

Tretinoin

Generic Formulation: TretinoinSpecialty: Dermatology
Provider Metrics Summary
Total Claims 17
30-Day Fills 25.0
Days Supply 712
MN State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills18.2
Peer Average Days Supply499
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,623.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$95.52

State Avg Cost Per Claim

$172.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).

Therapeutic Applications

This medication is used to treat acne. It may decrease the number and severity of acne pimples and promote quick healing of pimples that do develop. Tretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells.

Triamcinolone Acetonide

Generic Formulation: Triamcinolone AcetonideSpecialty: Dermatology
Provider Metrics Summary
Total Claims 75
30-Day Fills 107.3
Days Supply 2,896
MN State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills33.5
Peer Average Days Supply783
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 150.0% higher than the standard regional baseline profile for MN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,046.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.96

State Avg Cost Per Claim

$10.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.

Therapeutic Applications

This medication is used in a variety of conditions such as allergic disorders, arthritis, gout, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders, collagen and skin diseases. Talk to your doctor about the risks and benefits of triamcinolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Triamcinolone is known as a corticosteroid hormone (glucocorticoid). It works by decreasing your body's immune response to these diseases and reduces symptoms such as swelling.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. SARAH UTZ PETRY M.D. provides transparency into local medical care patterns within Duluth, MN.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Dermatology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.